Literature DB >> 9374813

DHEA protects against visceral obesity and muscle insulin resistance in rats fed a high-fat diet.

P A Hansen1, D H Han, L A Nolte, M Chen, J O Holloszy.   

Abstract

Visceral obesity is frequently associated with muscle insulin resistance. Rats fed a high-fat diet rapidly develop obesity and insulin resistance. Dehydroepiandrosterone (DHEA) has been reported to protect against the development of obesity. This study tested the hypothesis that DHEA protects against the increase in visceral fat and the development of muscle insulin resistance induced by a high-fat diet in rats. Feeding rats a diet providing 50% of the energy as fat for 4 wk resulted in a twofold greater visceral fat mass and a 50% lower rate of maximally insulin-stimulated muscle 2-deoxyglucose (2-DG) uptake compared with controls. Rats fed the high-fat diet plus 0.3% DHEA were largely protected against the increase in visceral fat (+ 11.3 g in high fat vs. + 2.9 g in high fat plus DHEA, compared with controls) and against the decrease in insulin-stimulated muscle 2-DG uptake (0.94 +/- 0.15 mumol.ml-1.20 min-1, controls; 0.46 +/- 0.06 mumol.ml-1.20 min-1, high-fat diet; 0.78 +/- 0.07 mumol.ml-1.20 min-1, high fat + DHEA). DHEA did not affect food intake. These results show that DHEA has a protective effect against accumulation of visceral fat and development of muscle insulin resistance in rats fed a high-fat diet.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9374813     DOI: 10.1152/ajpregu.1997.273.5.R1704

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

1.  Diet-induced obesity causes hypothalamic neurochemistry alterations in Swiss mice.

Authors:  Rosiane de Bona Schraiber; Aline Haas de Mello; Michelle Lima Garcez; Gustavo de Bem Silveira; Rubya Pereira Zacaron; Mariana Pereira de Souza Goldim; Josiane Budni; Paulo Cesar Lock Silveira; Fabrícia Petronilho; Gabriela Kozuchovski Ferreira; Gislaine Tezza Rezin
Journal:  Metab Brain Dis       Date:  2019-01-11       Impact factor: 3.584

2.  A family-based association study identified CYP17 as a candidate gene for obesity susceptibility in Caucasians.

Authors:  H Yan; Y Guo; T-L Yang; L-J Zhao; H-W Deng
Journal:  Genet Mol Res       Date:  2012-08-06

3.  Low dehydroepiandrosterone sulfate is associated with increased risk of ischemic stroke among women.

Authors:  Monik C Jiménez; Qi Sun; Markus Schürks; Stephanie Chiuve; Frank B Hu; Joann E Manson; Kathryn M Rexrode
Journal:  Stroke       Date:  2013-05-23       Impact factor: 7.914

4.  Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone.

Authors:  Noriyuki Homma; Tetsutaro Nagaoka; Vijaya Karoor; Masatoshi Imamura; Laimute Taraseviciene-Stewart; Lori A Walker; Karen A Fagan; Ivan F McMurtry; Masahiko Oka
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-09       Impact factor: 5.464

Review 5.  Dehydroepiandrosterone on metabolism and the cardiovascular system in the postmenopausal period.

Authors:  Caio Jordão Teixeira; Katherine Veras; Carla Roberta de Oliveira Carvalho
Journal:  J Mol Med (Berl)       Date:  2019-11-12       Impact factor: 4.599

6.  Dehydroepiandrosterone (DHEA) prevents the prostanoid imbalance in mesenteric bed of fructose-induced hypertensive rats.

Authors:  Horacio A Peredo; Marcos Mayer; Ileana R Faya; Ana M Puyó; Andrea Carranza
Journal:  Eur J Nutr       Date:  2008-08-25       Impact factor: 5.614

Review 7.  A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial?

Authors:  Nikolaos Samaras; Dimitrios Samaras; Emilia Frangos; Alexandre Forster; Jacques Philippe
Journal:  Rejuvenation Res       Date:  2013-08       Impact factor: 4.663

8.  Sex-related differences in the effects of high-fat diets on DHEA-treated rats.

Authors:  Ana Lúcia Cecconello; Marcia Trapp; Ana Lúcia Hoefel; Cláudia Vieira Marques; Bruno Dutra Arbo; Gabriela Osterkamp; Luiz Carlos Rios Kucharski; Maria Flávia Marques Ribeiro
Journal:  Endocrine       Date:  2014-10-10       Impact factor: 3.633

9.  Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension.

Authors:  Masahiko Oka; Vijaya Karoor; Noriyuki Homma; Tetsutaro Nagaoka; Eiko Sakao; Scott M Golembeski; Jennifer Limbird; Masatoshi Imamura; Sarah A Gebb; Karen A Fagan; Ivan F McMurtry
Journal:  Cardiovasc Res       Date:  2007-02-12       Impact factor: 10.787

10.  Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans.

Authors:  Edward P Weiss; Dennis T Villareal; Luigi Fontana; Dong-Ho Han; John O Holloszy
Journal:  Aging (Albany NY)       Date:  2011-05       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.